Literature DB >> 18036417

Management outcomes following lateral temporal bone resection for ear and temporal bone malignancies.

Michael G Moore1, Daniel G Deschler, Michael J McKenna, Mark A Varvares, Derrick T Lin.   

Abstract

OBJECTIVE: To evaluate clinical outcomes following lateral temporal bone resection (LTBR) for management of malignancies involving the ear or temporal bone. SUBJECTS AND METHODS: A retrospective medical record review was performed on patients receiving LTBR for management of malignancies involving the ear or temporal bone between 1990 and 2007.
RESULTS: In this group of 35 patients, the mean age was 62.7 years, with tumor histopathologies including squamous cell carcinoma (SCC, 20), basal cell carcinoma (BCC, 7), adenoid cystic carcinoma (ACC, 7), and adenocarcinoma (1). The 5-year overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were 77%, 79%, and 52%, respectively. Complete resection resulted in improved OS, DSS, and DFS (P < 0.004 for each) and reduced local recurrence (P < 0.001).
CONCLUSIONS: In patients with carcinomas of the ear and temporal bone, upfront excision including LTBR is an effective management when combined with postoperative radiation therapy. Complete removal of all disease may improve survival and decrease recurrence.

Entities:  

Mesh:

Year:  2007        PMID: 18036417     DOI: 10.1016/j.otohns.2007.09.010

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  17 in total

1.  Outcomes following temporal bone resection.

Authors:  Nichole R Dean; Hilliary N White; Dale S Carter; Renee A Desmond; William R Carroll; Benjamin M McGrew; Eben L Rosenthal
Journal:  Laryngoscope       Date:  2010-08       Impact factor: 3.325

2.  Treatment and outcome of middle ear cancer.

Authors:  Xianhao Jia; Qin Liang; Fanglu Chi
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10       Impact factor: 2.503

3.  Update on Surgical Outcomes of Lateral Temporal Bone Resection for Ear and Temporal Bone Malignancies.

Authors:  Sumi Sinha; Matthew M Dedmon; Matthew R Naunheim; Jennifer C Fuller; Stacey T Gray; Derrick T Lin
Journal:  J Neurol Surg B Skull Base       Date:  2016-06-10

Review 4.  Temporal bone resection for lateral skull-base malignancies.

Authors:  Gautam U Mehta; Thomas J Muelleman; Derald E Brackmann; Paul W Gidley
Journal:  J Neurooncol       Date:  2020-02-27       Impact factor: 4.130

5.  Parotid and temporal bone resection for skull base malignancies: outcome.

Authors:  Zoukaa Sargi; Robert Gerring; Simon Angeli; David Arnold; Adrien Eshraghi; Francisco Civantos; Fred Telischi; Donald Weed
Journal:  Skull Base       Date:  2010-05

6.  Tympanic Membrane and Ossicular-Sparing Modified Lateral Temporal Bone Resection.

Authors:  Yaser Ghavami; Yarah M Haidar; Marlon Maducdoc; Tjoson Tjoa; Omid Moshtaghi; Harrison W Lin; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2017-06-13       Impact factor: 3.497

7.  Clinical Analysis of En Bloc Resection for Advanced Temporal Bone Squamous Cell Carcinoma.

Authors:  Noritaka Komune; Daisuke Kuga; Satoshi Matsuo; Masaru Miyazaki; Teppei Noda; Kuniaki Sato; Takahiro Hongo; Kensuke Koike; Ryutaro Uchi; Ryunosuke Kogo; Nana Akagi Tsuchihashi; Shogo Masuda; Takashi Nakagawa
Journal:  J Neurol Surg B Skull Base       Date:  2021-02-12

8.  Ceruminous gland carcinomas: a clinicopathologic and immunophenotypic study of 17 cases.

Authors:  Nikhil Crain; Brenda L Nelson; E Leon Barnes; Lester D R Thompson
Journal:  Head Neck Pathol       Date:  2008-12-03

9.  Primary squamous cell carcinoma of the external auditory canal: surgical treatment and long-term outcomes.

Authors:  A Mazzoni; G Danesi; E Zanoletti
Journal:  Acta Otorhinolaryngol Ital       Date:  2014-04       Impact factor: 2.124

10.  Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF-CRT) for locally advanced squamous cell carcinoma of the external auditory canal.

Authors:  Hirotaka Shinomiya; Natsumi Uehara; Takeshi Fujita; Daisuke Miyawaki; Yoshinori Imamura; Masanori Teshima; Akinobu Kakigi; Naomi Kiyota; Ryohei Sasaki; Ken-Ichi Nibu
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-07-14       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.